Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma (NCT02801487)Shanghai Proton and Heavy Ion Center2015-09-01
Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma (NCT01404156)Dr. Gordon Buduhan2015-09-01
Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults (NCT02729571)Biofabri, S.L2015-09-01
Tenoxicam for Intrapartum Analgesia (NCT02549118)Ain Shams Maternity Hospital2015-09-01
Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients (NCT02466685)Herbert Meltzer2015-09-01
TCOT Effectiveness in Preventing Wound Infections in Perineal Resections (NCT02374294)Neogenix, LLC dba Ogenix2015-09-01
Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy (NCT02948075)NewVac LLC2015-09-01
Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy (NCT02556801)HAL Allergy2015-09-01
A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT02550873)Hoffmann-La Roche2015-09-01
Local Infiltration Analgesia in Total Knee Arthroplasty (NCT03206554)Asklepieion Voulas General Hospital2015-09-01
Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients (NCT03002038)Isfahan University of Medical Sciences2015-09-01
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia (NCT02411578)Jaeb Center for Health Research2015-09-01
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia (NCT02477670)Otsuka Pharmaceutical Development & Commercialization, Inc.2015-09-01
Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus (NCT02529449)Astellas Pharma Inc2015-09-01
The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity (NCT02814617)Chonbuk National University Hospital2015-09-01
Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer (NCT02558959)Zhejiang University2015-09-01
Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS (NCT02231008)Vanda Pharmaceuticals2015-09-01
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer (NCT02567383)Shin Kong Wu Ho-Su Memorial Hospital2015-09-01
Recombinant Human Interferon a-2b Gel for HPV-16 and/ or HPV-18 Gynecological Infections (NCT02801383)Lee's Pharmaceutical Limited2015-09-01
Caudal Block vs Local Wound Infiltration for Hernia Repair in Children (NCT02620566)University Clinic for Anesthesia Reanimation and Intensive Care Mother Theresa2015-09-01
Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock (NCT01901471)Hospices Civils de Lyon2015-09-01
Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease (NCT02949375)GRI Bio Operations, Inc.2015-09-01
Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes (NCT02544321)University of Colorado, Denver2015-09-01
Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission (NCT02530125)Northwestern University2015-09-01
Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients (NCT02651376)Beijing 302 Hospital2015-09-01
UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment (NCT02499081)University of Arkansas2015-09-01
Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy (NCT02433236)Rigel Pharmaceuticals2015-09-01
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome (NCT02591199)Urigen2015-09-01
Neoadjuvant Propanolol in Breast Cancer (NCT02596867)Texas Tech University Health Sciences Center, El Paso2015-09-01
Titrating-Dose of Lonafarnib in Combination With Ritonavir (NCT02527707)Eiger BioPharmaceuticals2015-09-01
Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage (NCT02165644)University of Florida2015-09-01
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT) (NCT02417974)Boston Medical Center2015-09-01
A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia (NCT02542852)Castagna Antonella2015-09-01
Cbt for Psychosis and Affect on Psychosis Symptoms (NCT02653729)Aisha Andleeb2015-09-01
Treatment With AZD4547 for Recurrent Malignant Glioma Expressing FGFR-TACC Gene Fusion" (NCT02824133)Assistance Publique - Hôpitaux de Paris2015-09-01
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy (NCT02559778)Giselle Sholler2015-09-01
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction (NCT02554253)Mayo Clinic2015-09-01
Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging (NCT02451540)FLUIDDA nv2015-09-01
PRF+1% MF for Class II Mandibular Furcation Defects (NCT03207698)Government Dental College and Research Institute, Bangalore2015-09-01
A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 (NCT02512588)Balance Therapeutics2015-09-01
CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients (NCT02575261)Fuda Cancer Hospital, Guangzhou2015-09-01
Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery (NCT03527381)Nikolay Kamenshchikov2015-09-01
Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes (NCT02583919)Ionis Pharmaceuticals, Inc.2015-09-01
The Effect of Baked Milk on Cow's Milk Allergy (NCT02738060)Hossein Esmaielzadeh2015-09-01
Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis (NCT02632201)Second Military Medical University2015-09-01
To Test the Effect of Calcifediol Hy.D Supplementation on Muscle Function and Bone Quality in Younger Postmenopausal Women With Osteopenia (NCT02527668)dsm-firmenich Switzerland AG2015-09-01
Yallaferon in Chinese Population (NCT02593968)Lee's Pharmaceutical Limited2015-09-01
A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway (NCT02544997)Samsung Medical Center2015-09-01
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis (NCT02565732)Revance Therapeutics, Inc.2015-09-01
A New Track Ablation Device for Liver Biopsy: A Feasibility Study (NCT02521129)Samsung Medical Center2015-09-01
Effect of a Synbiotic on Symptoms of Patients With STC (NCT02844426)Jinling Hospital, China2015-09-01
Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction (NCT01967251)Takeda2015-09-01
Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis (NCT02558543)Assistance Publique Hopitaux De Marseille2015-09-01
Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors (NCT02386501)Advaxis, Inc.2015-09-01
Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy. (NCT02560337)Vejle Hospital2015-09-01
Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects (NCT02659488)Lindner Center of HOPE2015-09-01
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer (NCT02605811)Guangzhou Medical University2015-09-01
Doxycycline in Human Pulmonary Tuberculosis (NCT02774993)National University Hospital, Singapore2015-09-01
CSL Behring Sclero XIII (NCT02551042)University College, London2015-09-01
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults (NCT00890149)University of Maryland, Baltimore2015-09-01
Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus (NCT02455011)REMD Biotherapeutics, Inc.2015-09-01
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster (NCT03318614)Universiti Sains Malaysia2015-09-01
Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy (NCT02607254)Johns Hopkins University2015-09-01
Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects (NCT02568319)Neothetics, Inc2015-09-01
Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance (NCT02621060)University of Guadalajara2015-09-01
Comparison of Efficacy Of Probiotic Toothpaste and Chlorhexidine Mouthwash To Reduce S.Mutans (NCT03004196)Peoples University, Bhanpur, Bhopal2015-09-01
Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery (NCT02617069)Meshalkin Research Institute of Pathology of Circulation2015-09-01
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease (NCT02561702)University of Rochester2015-09-01
Immunotherapy Using Autologous T Cell-Engineered With CD19-specific Chimeric Antigen Receptor for the Treatment of Recurrent /Refractory B Cell Leukemia (NCT02644655)Second Military Medical University2015-09-01
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients (NCT04406610)Fuda Cancer Hospital, Guangzhou2015-09-01
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease (NCT02774226)Augusta University2015-09-01
Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers. (NCT02534935)Pfizer2015-08-31
PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK) (NCT02438761)Institut Curie2015-08-31
Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung (NCT02485652)Hanmi Pharmaceutical Company Limited2015-08-31
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma (NCT02352831)Washington University School of Medicine2015-08-31
Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma (NCT02356458)Swiss Cancer Institute2015-08-31
Lenalidomide Maintenance in Plasma Cell Myeloma (NCT02538198)Memorial Sloan Kettering Cancer Center2015-08-31
REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression (NCT02584465)ARCAGY/ GINECO GROUP2015-08-28
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial (NCT02440958)Yonsei University2015-08-28
Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor (NCT02426086)Geron Corporation2015-08-28
Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) (NCT02513472)Eisai Inc.2015-08-28
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis (NCT02595008)Sun Pharmaceutical Industries, Inc.2015-08-28
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer (NCT02412670)ECOG-ACRIN Cancer Research Group2015-08-27
Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access (NCT02475837)Ken Mahaffey2015-08-26
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC) (NCT02437136)Syndax Pharmaceuticals2015-08-26
Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients. (NCT02315768)University of California, San Diego2015-08-26
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma (NCT02495103)National Cancer Institute (NCI)2015-08-26
A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) (NCT02502097)Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2015-08-26
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) (NCT02460198)Merck Sharp & Dohme LLC2015-08-25
GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma (NCT02495454)Fondazione Italiana Linfomi - ETS2015-08-25
Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin (NCT02420691)M.D. Anderson Cancer Center2015-08-25
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children (NCT02377427)GlaxoSmithKline2015-08-25
Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors (NCT02454972)PharmaMar2015-08-25
Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD (NCT02563782)Astellas Institute for Regenerative Medicine2015-08-24
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma (NCT02590263)AbbVie2015-08-24
Study of Efficacy of CDZ173 in Patients With APDS/PASLI (NCT02435173)Novartis Pharmaceuticals2015-08-24
Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration (NCT02507388)Alcon Research2015-08-24
Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL) (NCT02455297)Bayer2015-08-24
Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis (NCT02439385)Gachon University Gil Medical Center2015-08-24
LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib. (NCT02450903)Novartis Pharmaceuticals2015-08-21
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.